🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan flag Japan · Delayed Price · Currency is JPY
2,056.00
-7.00 (-0.34%)
Nov 18, 2026, 3:30 PM JST

Santen Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
661,577574,345484,047559,190424,342490,898
Market Cap Growth
29.17%18.66%-13.44%31.78%-13.56%-19.37%
Enterprise Value
578,967511,855405,379476,424362,459422,435
Last Close Price
2056.001763.571369.591451.001043.211098.43

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
17.0415.3713.3521.00-18.04
Forward PE
16.2016.0614.1217.0925.0316.26
PS Ratio
2.231.971.611.851.521.84
PB Ratio
2.171.941.701.831.451.46
P/TBV Ratio
2.822.552.302.522.152.37
P/FCF Ratio
16.0215.678.928.8321.3617.11
P/OCF Ratio
13.3313.207.957.7011.4210.66
PEG Ratio
3.352.171.340.562.792.79

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
1.951.761.351.581.301.59
EV/EBITDA Ratio
8.797.936.126.776.907.98
EV/EBIT Ratio
12.1311.078.399.1310.2711.78
EV/FCF Ratio
14.0213.967.477.5218.2414.72

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
-0.120.120.110.120.10
Debt / EBITDA Ratio
-0.540.520.490.690.62
Debt / FCF Ratio
-0.950.630.551.821.15
Net Debt / Equity Ratio
-0.27-0.16-0.21-0.20-0.07-0.15
Net Debt / EBITDA Ratio
-1.24-0.71-0.89-0.85-0.41-0.95
Net Debt / FCF Ratio
-1.98-1.26-1.08-0.95-1.09-1.74
Asset Turnover
0.740.700.710.710.630.62
Inventory Turnover
1.952.102.722.992.952.79
Quick Ratio
1.931.741.902.001.851.91
Current Ratio
2.972.602.582.552.382.39
Return on Equity (ROE)
13.58%12.93%12.14%8.92%-4.75%8.45%
Return on Assets (ROA)
7.39%6.94%7.14%7.61%5.01%5.20%
Return on Invested Capital (ROIC)
17.01%15.37%15.46%18.05%12.64%10.12%
Return on Capital Employed (ROCE)
13.90%13.80%15.00%15.20%10.60%9.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
5.87%6.51%7.49%4.76%-3.52%5.54%
FCF Yield
6.24%6.38%11.21%11.33%4.68%5.85%
Dividend Yield
2.04%2.13%2.54%2.14%2.83%2.61%
Payout Ratio
31.57%33.83%33.40%44.59%-44.07%
Buyback Yield / Dilution
4.91%6.10%5.01%4.98%3.26%-0.02%
Total Shareholder Return
6.96%8.22%7.55%7.12%6.09%2.59%